KCNC CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. KCNC Gen Silencer sind erhältlich als KCNC CRISPR/Cas9 Knockout Plasmide und KCNC Double Nickase Plasmide. KCNC CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
KCNC CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
KCNC3 CRISPR/Cas9 KO Plasmid (h) | sc-407022 | h | Gene Knockout | GFP | 0 | ||
KCNC3 HDR Plasmid (h) | sc-407022-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
KCNC3 Double Nickase Plasmid (h) | sc-407022-NIC | h | Gene Knockout | Puromycin | 0 | ||
KCNC3 Double Nickase Plasmid (h2) | sc-407022-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
KCNC3 CRISPR/Cas9 KO Plasmid (m) | sc-421224 | m | Gene Knockout | GFP | 0 | ||
KCNC3 HDR Plasmid (m) | sc-421224-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
KCNC3 Double Nickase Plasmid (m) | sc-421224-NIC | m | Gene Knockout | Puromycin | 0 | ||
KCNC3 Double Nickase Plasmid (m2) | sc-421224-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
KCNC4 CRISPR/Cas9 KO Plasmid (h) | sc-408745 | h | Gene Knockout | GFP | 0 | ||
KCNC4 HDR Plasmid (h) | sc-408745-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
KCNC4 Double Nickase Plasmid (h) | sc-408745-NIC | h | Gene Knockout | Puromycin | 0 | ||
KCNC4 Double Nickase Plasmid (h2) | sc-408745-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
KCNC4 CRISPR/Cas9 KO Plasmid (m) | sc-430283 | m | Gene Knockout | GFP | 0 | ||
KCNC4 HDR Plasmid (m) | sc-430283-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
KCNC4 Double Nickase Plasmid (m) | sc-430283-NIC | m | Gene Knockout | Puromycin | 0 | ||
KCNC4 Double Nickase Plasmid (m2) | sc-430283-NIC-2 | m | Gene Knockout | Puromycin | 0 |
KCNC CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
KCNC3 CRISPR Activation Plasmid (h) | sc-407022-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC3 CRISPR Activation Plasmid (h2) | sc-407022-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC3 Lentiviral Activation Particles (h) | sc-407022-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC3 Lentiviral Activation Particles (h2) | sc-407022-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC3 CRISPR Activation Plasmid (m) | sc-421224-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC3 CRISPR Activation Plasmid (m2) | sc-421224-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC3 Lentiviral Activation Particles (m) | sc-421224-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC3 Lentiviral Activation Particles (m2) | sc-421224-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 CRISPR Activation Plasmid (h) | sc-408745-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 CRISPR Activation Plasmid (h2) | sc-408745-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 Lentiviral Activation Particles (h) | sc-408745-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 Lentiviral Activation Particles (h2) | sc-408745-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 CRISPR Activation Plasmid (m) | sc-430283-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 CRISPR Activation Plasmid (m2) | sc-430283-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 Lentiviral Activation Particles (m) | sc-430283-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
KCNC4 Lentiviral Activation Particles (m2) | sc-430283-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |